|
EDEM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31570000003489E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.67150000010652E-07 |
| Normal-vs-Stage2 |
8.584600E-04 |
| Normal-vs-Stage3 |
2.065400E-01 |
| Normal-vs-Stage4 |
4.772800E-01 |
| Stage1-vs-Stage2 |
7.428600E-01 |
| Stage1-vs-Stage3 |
5.243800E-02 |
| Stage1-vs-Stage4 |
2.117000E-01 |
| Stage2-vs-Stage3 |
2.342400E-01 |
| Stage2-vs-Stage4 |
4.474200E-01 |
| Stage3-vs-Stage4 |
9.922400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.54050000001594E-07 |
| Normal-vs-AfricanAmerican |
1.142130E-03 |
| Normal-vs-Asian |
1.091350E-01 |
| Caucasian-vs-AfricanAmerican |
6.756000E-01 |
| Caucasian-vs-Asian |
6.739600E-01 |
| AfricanAmerican-vs-Asian |
8.028000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25160000538938E-08 |
| Normal-vs-Female |
3.619800E-01 |
| Male-vs-Female |
3.764200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.260300E-03 |
| Normal-vs-Extreme_Weight |
1.02270000246207E-08 |
| Normal-vs-Obese |
3.515200E-03 |
| Normal-vs-Extreme_Obese |
8.033900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.122000E-01 |
| Normal_Weight-vs-Obese |
6.508400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.645800E-01 |
| Extreme_Weight-vs-Obese |
1.906390E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.835600E-01 |
| Obese-vs-Extreme_Obese |
7.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.574000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.038000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.29469999668552E-08 |
| Normal-vs-Age(81-100Yrs) |
1.03410000007464E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.698200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.881800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.635200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.199500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.282170E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.130950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.82179999869336E-08 |
| Normal-VS-Type2 PRCC |
2.007500E-04 |
| Normal-VS-KIRP CIMP |
5.157800E-01 |
| Normal-VS-Unclassified PRCC |
1.759760E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.903800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.510100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.124400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.896140E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.676590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.825240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0862999999528E-07 |
| Normal-vs-N1 |
9.582000E-01 |
| Normal-vs-N2 |
7.688600E-01 |
| N0-vs-N1 |
9.617200E-03 |
| N0-vs-N2 |
1.249240E-01 |
| N1-vs-N2 |
7.892800E-01 |
|
|
